News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


PHARMAC, DHBs welcome increased budget for 2006-07

PHARMAC, DHBs welcome increased budget for 2006-07

An $18 million increase in pharmaceutical funding has been approved for the 2006-07 financial year.

Minister of Health Pete Hodgson has approved a $600 million pharmaceutical budget for the 2006-07 financial year, following a joint recommendation from PHARMAC and District Health Boards. This continues the pattern of budget increases over recent years.

PHARMAC manages pharmaceutical spending on behalf of DHBs. The budget-setting process involves discussions between PHARMAC and DHBs, and a joint recommendation being taken to the Minister.

PHARMAC’s Acting Chief Executive Matthew Brougham says the Government’s commitment to increased pharmaceutical funding will help PHARMAC to improve New Zealanders’ health through subsidised medicines.

“PHARMAC is focused on investing in medicines and some significant funding decisions have been made,” says Matthew Brougham. “These include medicines such as temozolomide for brain tumours, adalimumab for rheumatoid arthritis and entacapone for Parkinsons disease.”

“This commitment to additional funding for 2006-07 will mean that we will be able to manage the impact of those decisions and continue to add new medicines to the subsidised list.”

Spokesman for the District Health Boards, Wairarapa DHB CEO David Meates, says new spending on pharmaceuticals benefits patients across all DHBs. PHARMAC’s management of spending also assists DHBs in managing their overall budgets.

“We look forward to patients continuing to access new medicines, and to continued efficiencies being made on some older medicines,” David Meates says.

PHARMAC will continue to invest in medicines that provide advancements over currently funded treatments, and those that provide good value for money, says Matthew Brougham. Areas of focus are likely to be treatments for cancer, HIV and diabetes. Already this financial year, PHARMAC has added a new long-acting insulin for diabetes, insulin glargine (Lantus), and widened access to treatments for prostate cancer (goserelin) and asthma (long acting beta agonists such as Oxis and Serevent).

Matthew Brougham and David Meates say PHARMAC and DHBs will continue to work together to ensure long-term decisions on pharmaceutical funding can continue to be made.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines

Howard Davis Article: A Musical Axis - Brahms, Wagner, Sibelius

Brahms' warm and exquisitely subtle Symphony No. 3 in F major, Wagner's irrepressibly sentimental symphonic poem Siegfried Idyll, and Sibelius' chilling and immensely challenging Violin Concerto in D minor exemplify distinct stages of development in a tangled and convoluted series of skirmishes that came to define subsequent disputes about the nature of post-Romantic orchestral writing well into the following century. More>>


Scoop Review Of Books: A Pale Ghost Writer

Reviewed by Ruth Brassington, Richard Flanagan's new novel is about a novelist hastily ghost-writing the biography of a crook about to go to trial. The reader is kept on a cliff-edge, as the narrator tries to get blood out of his stone man. More>>

Negotiations Begin: Equal Conditions For Men & Women In Professional Football

The trade union representing New Zealand's professional footballers has initiated bargaining for an agreement securing equal terms and conditions for men and women. If negotiated, it will be the first agreement of its kind in the world. More>>


New Zealand Wars Commemoration: Witi Ihimaera's Sleeps Standing Moetū

The second of several articles to mark Rā Maumahara, remembering the New Zealand Land Wars. The first was a Q&A with Vincent O’Malley, author of The Great War for New Zealand: Waikato 1800–2000. More>>


Howard Davis Review: Conflict & Resistance - Ria Hall's Rules of Engagement

From the aftermath of war through colonisation to her own personal convictions, Hall's new CD addresses current issues and social problems on multiple levels, confirming her position as a polemical and preeminent voice on the indigenous NZ music scene. More>>



  • Wellington
  • Christchurch
  • Auckland